CGM in Early Gestational Diabetes Improved Outcomes - Summary - MDSpire

CGM in Early Gestational Diabetes Improved Outcomes

Secondary outcomes favored CGM, including fewer preterm births and neonatal intensive care unit admissions.

  • By

  • Kathryn Wighton

  • April 22, 2026

  • 3 min

Share

Objective:

To evaluate the impact of continuous glucose monitoring (CGM) on maternal and neonatal outcomes in patients with gestational diabetes.

Key Findings:
  • Neonatal hypoglycemia was numerically lower with CGM (46% vs 65%), but not statistically significant.
Interpretation:

While CGM did not improve time in range, it was associated with significantly better maternal and neonatal outcomes, highlighting its potential benefits in managing gestational diabetes.

Limitations:
  • Control group also underwent blinded CGM, which may not provide a true standard-of-care comparison.
Conclusion:

CGM improved maternal and neonatal outcomes in gestational diabetes patients, despite no significant difference in time in range.

Original Source(s)

CGM in Early Gestational Diabetes Improved Outcomes

  • by Kathryn Wighton

  • April 22, 2026

Related Content

X Chromosome Loss Tied to Infertility

Women with higher LOX levels had more than double the odds of failing to conceive naturally.

Side Effects: Nobody Trained for This

Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.

Prepregnancy Lipids Predict HDP Risk

A large Swedish cohort found cardiometabolic biomarkers measured up to decades before pregnancy were associated with hypertensive disorders — with risk apparent even below standard diagnostic thresholds.